CGEM vs GILD: Which Stock is Better?
Side-by-side comparison of Cullinan Therapeutics Inc and Gilead Sciences Inc in 2026
CGEM
Cullinan Therapeutics Inc
$14.74
GILD
Gilead Sciences Inc
$138.55
Key Metrics Comparison
| Metric | CGEM | GILD | Winner |
|---|---|---|---|
| Market Cap | $904.87M | $173.48B | GILD |
| P/E Ratio | N/A | 20.61 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze CGEM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGEM or GILD a better investment?
Comparing CGEM and GILD: Cullinan Therapeutics Inc has a market cap of $904.87M while Gilead Sciences Inc has $173.48B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGEM and GILD?
CGEM (Cullinan Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGEM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGEM or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for CGEM.
Which company is more profitable: CGEM or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for CGEM.
Which is the larger company: CGEM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $173.48B compared to $904.87M for CGEM.
Should I buy CGEM or GILD in 2026?
Both CGEM and GILD have investment merit. CGEM trades at $14.74 while GILD trades at $138.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGEM and GILD stock?
Key differences: Market Cap ($904.87M vs $173.48B), P/E Ratio (N/A vs 20.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).